Home › Prostate Cancer › Oregon
Prostate Cancer clinical trials in Oregon
38 studies for Prostate Cancer are looking for participants at sites in Oregon.
Cities in Oregon
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Providence Newberg Medical Center, Newberg
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Willamette Falls Medical Center, Oregon City
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
RecruitingPhase 4
Ages 18 and older · Men · Updated Nov 5, 2026 · NCT07569926cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06632977A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06095089Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07200830A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 30, 2026 · NCT06925737A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Oct 26, 2026 · NCT05593497Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
RecruitingObservational study
Ages 18 to 120 · Men · Updated Oct 26, 2026 · NCT04706663Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 19, 2026 · NCT07611110A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 16, 2026 · NCT06879041Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Portland
- Research Site, Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 15, 2026 · NCT07711002Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
RecruitingPhase 1/2
Ages 18 to 99 · Men · Updated Oct 14, 2026 · NCT07590934A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT06952803EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT06049355FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 31, 2026 · NCT05726292Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- and 8 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 25, 2026 · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 15, 2026 · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · Men · Updated May 15, 2026 · NCT04472338Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
Recruiting
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
Recruiting
Ages 65 and older · Men · Updated May 6, 2026 · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- and 9 more
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
RecruitingPhase 3
Ages 18 and older · Men · Updated Jan 22, 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Apr 20, 2022 · NCT03753243From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.